Anti-tumour activity of flavone acetic acid (NSC 347512) in mice – influence of immune status
Open Access
- 1 January 1991
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 63 (1) , 57-62
- https://doi.org/10.1038/bjc.1991.12
Abstract
Flavone acetic acid (FAA) is a synthetic flavonoid with dramatic pre-clinical anti-tumour activity involving a vascular component in its mechanism but no clinical effects have been seen to date. As FAA also has immunomodulatory activity, immunological factors might explain differences in activity between mouse and man. This study examines the influence of host immune status on the anti-tumour activity of FAA. Two human colon tumour xenografts (COBA, HT-29) fail to respond to FAA in nude mice. The lack of activity of FAA against HT-29 xenografts cannot be explained on the basis of limited drug bioavailability as achievable plasma, and tumour levels of FAA are similar to those seen in sensitive murine colon tumours. The immune status of the host also influences the activity of FAA against two transplantable tumours of the mouse colon. Both these tumours are highly responsive to FAA in their normal NMRI hosts, but neither tumours exhibited significant growth delay in thymectomised NMRI or nude hosts. Histological examination of treated tumours revealed significant areas of haemorrhagic necrosis in all three hosts. These data suggest a clear immunological component in the mechanism of action of FAA which is separate from the previously described haemorrhagic necrosis.Keywords
This publication has 24 references indexed in Scilit:
- Vascular collapse after flavone acetic acid: A possible mechanism of its anti-tumour actionEuropean Journal of Cancer and Clinical Oncology, 1989
- Pharmacokinetics and anti-tumour activity of LM985 in mice bearing transplantable adenocarcinomas of the colonBritish Journal of Cancer, 1987
- Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agentEuropean Journal of Cancer and Clinical Oncology, 1987
- In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015)European Journal of Cancer and Clinical Oncology, 1987
- Induction of natural killer cell activity by the antitumour compound flavone acetic acid (NSC 347 512)European Journal of Cancer and Clinical Oncology, 1987
- Characterization of a Transplantable Adenocarcinoma of the Mouse Colon Producing Cachexia in Recipient Animals2JNCI Journal of the National Cancer Institute, 1987
- Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid)British Journal of Cancer, 1987
- FLAVONE ACETIC-ACID - A NOVEL AGENT WITH PRECLINICAL ANTITUMOR-ACTIVITY AGAINST COLON ADENOCARCINOMA 38 IN MICE1986
- A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous originBritish Journal of Cancer, 1976
- Similarities of the Anti-tumour Actions of Endotoxin, Lipid A and Double-stranded RNABritish Journal of Cancer, 1973